A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Elbasvir | CAS 1370468-36-2 - Request Quote

Picture of Elbasvir
SZ CAT No:SZ-E134001
CAS No
1370468-36-2
Mol.F.
C49H55N9O7
Mol.Wt.
882
Inv. Status
In Stock
Shipping Condition Room Temperature

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Elbasvir is chemically Dimethyl ((2S,2'S)-((2S,2'S)-(((S)-6-phenyl-6H-benzo[5,6][1,3]oxazino[3,4-a]indole-3,10-diyl)bis(1H-imidazole-5,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-1,2-diyl))dicarbamate. Elbasvir is supplied with detailed characterization data compliant with regulatory guideline. Elbasvir can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Elbasvir.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 1370468-36-2

Purchase 1370468-36-2

Order 1370468-36-2

Enquire 1370468-36-2

price of 1370468-36-2

1370468-36-2 Supplier

1370468-36-2 Manufacturer

1370468-36-2 Exporter

buy high quality Elbasvir

Purchase Elbasvir

Elbasvir suppliers

Elbasvir manufacturers

Elbasvir price

Order Elbasvir

Enquire Elbasvir

Elbasvir cost

Elbasvir Supplier

Elbasvir Distributor

Elbasvir for Method Validation

Elbasvir Reference Standard

Elbasvir for ANDA Filing

Elbasvir for Forced Degradation Studies

Elbasvir Identification Standards

Elbasvir for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,